Parnell Pharmaceuticals (OTCMKTS:PARNF) Shares Up 37.5% – Should You Buy?

Parnell Pharmaceuticals Holdings Ltd (OTCMKTS:PARNFGet Free Report) shares shot up 37.5% during mid-day trading on Thursday . The stock traded as high as $0.19 and last traded at $0.17. 10,000 shares changed hands during trading, a decline of 53% from the average session volume of 21,500 shares. The stock had previously closed at $0.12.

Parnell Pharmaceuticals Price Performance

Parnell Pharmaceuticals Company Profile

(Get Free Report)

Parnell Pharmaceuticals Holdings Ltd, a commercial-stage pharmaceutical company, focuses on developing, manufacturing, and marketing animal pharmaceutical products worldwide. The company operates through four segments: Companion Animal, Production Animal – U.S., Production Animal – Rest of World, and Manufacturing Operations.

Featured Articles

Receive News & Ratings for Parnell Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Parnell Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.